Effect of Rebound Exercise in Individuals With Type 2 Diabetes

University of KwaZulu60 enrolled

Overview

The purpose of this study was to investigate the effect of rebound exercise (mini trampoline jumping) on metabolic outcomes and quality of life in patients with Type 2 Diabetes.

The exercise involved jumping on the mini trampoline with feet slightly apart. Participants stood on the mid portion of the trampoline bed and made repeated up-and-down bouncy movements. Each foot strike equals one step or bounce. With each landing, the mat of the trampoline underwent deformation and the springs released the energy stored in them such that the participant was made to bounce off the mat. Exercise was administered for between 10 - 15 minutes after which a 5-minute period of rest was allowed. A heart rate monitor was used to guide the intensity of the exercise in the moderate range. Each participant accumulated between 20 and 30 minutes of rebound exercise (bouncing on a mini trampoline) per session, administered three times per week for 12 weeks. All data were captured at baseline and at the end of the 12-week intervention period.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Type 2 Diabetes

Interventions

Rebound exerciseOTHER

Repeated jumping on a mini trampoline was administered

Eligibility

Sex: ALLMin age: 30 YearsMax age: 60 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 30- to 60-year-old male and female individuals; * A diagnosis of type 2 diabetes ≤ 5 years; * Attendance at the Diabetes Outpatient Clinics of Aminu Kano Teaching Hospital and Murtala Muhammad Specialist Hospital in Kano, Northwestern Nigeria; * Self-ambulatory; * An inactive lifestyle over the last year. Exclusion Criteria: * A diagnosis of type 2 diabetes for more than 5 years; * Hypertension (systolic and diastolic blood pressure more than 140 and 90 mmHg, respectively) or treatment for hypertension; * Use of insulin therapy * Lower limb weakness and/or deformities with loss of protective sensation in the feet; * Back, shoulder or knee problems and/or joint instability; * History of coronary artery disease, retinopathy and nephropathy; * Myocardial infarction, cardiac or abdominal surgery within the previous 6 months; * History of fractures of the spine, hip, knee and/or ankle joints.

Outcomes

Primary Outcomes

Glycated hemoglobin

Glycated hemoglobin was assessed using the mini-column ion-exchange chromatographic method and expressed in percentage

Time frame: 3 months

Secondary Outcomes

Fasting plasma glucose

Fasting plasma glucose (in molar concentration) was measured by glucose oxidase assay using a glucose analyzer

Time frame: 3 months

Fasting insulin

Fasting insulin (in gravimetric unit) was determined using a commercially available ELISA human insulin kit

Time frame: 3 months

High-density lipoprotein cholesterol

High-density lipoprotein cholesterol (in molar concentration) was enzymatically determined using commercial kits

Time frame: 3 months

Total cholesterol

Total cholesterol (in molar concentration) was enzymatically determined using commercial kits

Time frame: 3 months

Triglycerides

Triglycerides (in molar concentration) were enzymatically determined using commercial kits

Time frame: 3 months

Low-density lipoprotein cholesterol

Low-density lipoprotein cholesterol (in molar concentration) was estimated using the Friedewald formula.

Time frame: 3 months

Quality of life

The short-form 36 health questionnaire was used to assess participants' quality of life and expressed in percentage

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.